Unknown PHASE2 INTERVENTIONAL 2-arm NCT01055990

Basic and Clinical Research on Applying Blood Fix to Treat Critical H1N1 Patients

Phase1 An Observational Clinical Trial With an Influenza A (H1N1) 2009 Monovalent,Split-virion Vaccine in Healthy Adults, Aged 18-60 Years Phase2 Basic and Clinical Research on Applying Blood Fix to Treat Critical H1N1 Patients

Sponsor: Beijing Ditan Hospital

Conditions Influenza Orthomyxoviridae Infections Respiratory Tract Diseases Respiratory Tract Infections Virus Diseases

Interventions blood fix split-virion, non-adjuvanted H1N1 vaccine of 15 μg

Updated 4 times since 2017 Last updated: Jan 25, 2010 Started: Oct 31, 2009 Primary completion: Apr 30, 2010 Completion: May 31, 2010

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01055990, this PHASE2 trial focuses on Influenza and Orthomyxoviridae Infections and remains ongoing. Sponsored by Beijing Ditan Hospital, it has been updated 4 times since 2009, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE2
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE2

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE2
Jan 2017 — Jan 2021 [monthly]

Unknown Status PHASE2

First recorded

Oct 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Beijing Ditan Hospital
National Institute for the Control of Pharmaceutical and Biological Products, China
Shanghai Public Health Clinical Center

Data source: Shanghai Public Health Clinical Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Shanghai, China